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Abstract
The role of myeloid cells in supporting cancer growth is well established. Most work has focused on myeloid-derived
suppressor cells (MDSC) that accumulate in tumor-bearing animals, but tumor-associated neutrophils (TAN) are also known
to be capable of augmenting tumor growth. However, little is known about their evolution, phenotype, and relationship to
naı ¨ve neutrophils (NN) and to the granulocytic fraction of MDSC (G-MDSC). In the current study, a transcriptomics approach
was used in mice to compare these cell types. Our data show that the three populations of neutrophils are significantly
different in their mRNA profiles with NN and G-MDSC being more closely related to each other than to TAN. Structural genes
and genes related to cell-cytotoxicity (i.e. respiratory burst) were significantly down-regulated in TAN. In contrast, many
immune-related genes and pathways, including genes related to the antigen presenting complex (e.g. all six MHC-II
complex genes), and cytokines (e.g. TNF-a, IL-1-a/b), were up-regulated in G-MDSC, and further up-regulated in TAN.
Thirteen of the 25 chemokines tested were markedly up-regulated in TAN compared to NN, including striking up-regulation
of chemoattractants for T/B-cells, neutrophils and macrophages. This study characterizes different populations of
neutrophils related to cancer, pointing out the major differences between TAN and the other neutrophil populations.
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Introduction
Various types of myeloid cells have been shown to promote
tumor progression by direct immune suppression [1] and by
production of angiogenic factors, matrix-degrading enzymes, or
growth factors [2,3]. The best characterized of these cells have
been tumor-associated macrophages (TAM) that have properties
of alternatively activated macrophages, also known as M2
macrophages [1]. We have recently shown that, similar to
TAM, tumor-associated neutrophils (TAN) also have differential
states of activation/differentiation. We demonstrated that in
tumors, TAN develop a pro-tumorigenic (N2) phenotype, largely
driven by the presence of TGF-b. Blocking TGF-b changes the
characteristics of these cells to a more anti-tumorigenic (N1)
phenotype [4]. IFN-b has been suggested to polarize this
dichotomy in a reciprocal way, favoring the N1 phenotype [5].
In untreated tumors, neutrophils have been reported to produce
angiogenic factors and matrix-degrading enzymes [6,7], support
the acquisition of a metastatic phenotype [8], and suppress the
anti-tumor immune response [9]. Depletion of these TAN inhibits
tumor growth [4,6,10] and reduces the level of immunosuppres-
sion in the tumor microenvironment, allowing for increased
activity of CD8
+ cytotoxic T-lymphocytes (CTL) [4]. The broad
spectrum of activities of TAN in the context of tumor biology has
been recently reviewed [11].
Neutrophils, like all other leukocytes, move into tissues from the
blood under the influence of specific chemokines (e.g. KC/CXCL-
1, MIP-2a/CXCL-2 and GCP-2/CXCL-6), cytokines (e.g. TNF-
a and IFN-x), and cell adhesion molecules located on their own
surface (e.g. CD11b) and on the surface of endothelial cells (e.g.
selectins, ICAM-1 and PECAM-1) [12]. When they traffic into
tumors, they are referred to as TAN. In mice, TAN can be defined
by the specific surface markers CD11b and Ly6G with low
expression of macrophage markers such as F4/80 [13].
Myeloid-derived suppressor cells (MDSC) are a heterogeneous
population of immune suppressive cells that are produced
excessively in cancer. They comprise at least two subsets -
granulocytic (Ly6G
+) and monocytic cells (Ly6C
+), potentially with
different immunosuppressive properties [14]. It has been previ-
ously shown that MDSC can enter tumors and differentiate to
mature macrophages (TAM) or neutrophils (TAN) [15]. However,
since no definitive markers have been established, it is unknown
whether intratumoral N2 neutrophils (N2 TAN) are granulocytic
MDSC from spleen that are attracted to the tumor or if they are
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31524typical blood-derived neutrophils that are then converted to an N2
phenotype by the tumor microenvironment, specifically by the
high local concentrations of TGF-b.
The purpose of this study was to use a transcriptomics approach
to gain further information about TANs by comparing the RNA
profile of these cells to naı ¨ve bone-marrow neutrophils (NN) and to
the granulocytic fraction of myeloid derived suppressor cells (G-
MDSC). We examined which pathways and gene-groups varied
amongst these 3 populations of neutrophils and performed a
detailed analysis on pathways related to the main functions of
neutrophils, such as respiratory burst, granule proteins, phagocy-
tosis, apoptosis, structural genes, antigen presentation and specific
immune effects. Our data defines TAN as a unique population of
neutrophils, quite distinct from both NN and G-MDSC.
Results
Preparation of samples
mRNA preparations were extracted from individual non-tumor-
bearing mice (NN) or from mice in which AB12 mesothelioma
tumors were growing (G-MDSC and TAN). For each experimen-
tal ‘‘sample’’, equivalent amounts of mRNA were pooled from 2–4
extractions (according to the yield of neutrophils) for the
transciptome analysis. We prepared multiple independent samples
from each of the neutrophil populations studied - NN (n=7), G-
MDSC (n=4) and TAN (n=4).
Hierarchical clustering of neutrophils
As a first step, gene probes were filtered, resulting in 12,129
informative probes. Hierarchical clustering (Fig. 1A) and principal
component analysis (PCA) (Fig. 1B) showed that the three types of
myeloid cells are distinct groups, with the bone marrow neutrophils
(NN), granulocytic fraction of myeloid-derived suppressor cells (G-
MDSC), and tumor-associated neutrophils (TAN) clearly separated.
Hierarchical clustering suggested that NN and G-MDSC seemed
more closely related to each other than to TAN (Fig. 1A).
Genomewide RNA expression profiles
Whole murine genome RNA expression profiles of neutrophils
from the three different groups were compared to each other to
discern more specific differences. There were 8,355 genes that
were significantly different when comparing NN to G-MDSC
(p,0.05, FDR=3%). The fold changes were larger than 1.7 in
2,489 of the genes. Of these genes, 1,189 were up-regulated and
1,300 down-regulated in G-MDSC compared to NN. Three of the
top-5 up-regulated genes in G-MDSC were chemokines (CXCL-2,
CCL-3 and CCL-4), that were changed by more than 40-fold
(Table S1).
There were 11,035 genes that were significantly different
between NN and TAN (p,0.05, FDR=1%). Of these, 5,846
had a fold-change of more than 1.7-fold; 2,983 were up-regulated
and 2,863 down-regulated in TAN compared to NN. Seven of the
top-10 up-regulated in TAN were chemokines, all by more than
70-fold (Table S2).
There were 10,172 genes significantly different (p,0.05,
FDR=2%) between G-MDSC and TAN. Of these, 5,344 had a
fold-change of more than 1.7-fold; 2,803 genes were up-regulated
and 2,541 down-regulated in TAN compared to G-MDSC. Again,
three of the top-5 up-regulated in TAN were chemokines (CCL-7,
CCL-8 and CCL-12), all by more than 80-fold (Table S3).
Figure 1. Hierarchical clustering (A) and principal component analysis (PCA) (B) of the samples, showing that the three groups of
neutrophils are distinct. % - Naı ¨ve neutrophils (NN); * - Granulocytic fraction of MDSC (G-MDSC). e - Tumor associated neutrophils (TAN).
doi:10.1371/journal.pone.0031524.g001
TAN Differ from Naı ¨ve Neutrophils and G-MDSC
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31524In order to further compare these differences, heatmaps of the
genes most changed between the groups were prepared. Figure 2A
shows a heatmap including all genes with a fold-change between
samples $30. The TAN exhibit a signature that is markedly
different than the other two types of neutrophilic cells, suggesting
that the TAN are not G-MDSC that have simply entered the
tumor. Figure 2B compares NN and G-MDSC, showing all genes
with a fold-change $8. It can be noted clearly that the signature of
these two groups of cells differ, suggesting that the G-MDSC have
changed from the bone marrow neutrophils (NN).
Validation of gene array results by RT-PCR and ELISA
Recent technological improvements have increased the reproduc-
ibility and reliability of microarray results [16]. Most microarray
results are now highly accurate, especially for highly regulated genes,
and differences between microarray- and PCR-generated data occur
mostly in the amplitude of the detected expression change [17,18].
Nevertheless, we conducted real-time PCR validation of some of the
gene expression changes in TAN versus NN mentioned in the results
section. In addition, we validated some of the genes using cells from
animals bearing a different cell line, the lung cancer LKR line, in a
different mouse strain (Table 1). In general, the results were highly
concordant between the RT-PCR in both cell lines and microarray
data, especially regarding the direction of change in expression,
although some differences in the extent of change were found,
possibly related to technical differences between the methods (e.g. in
MMP-9). One exception was VEGF. Whereas in the array the level
of mRNA for VEGF in TAN was higher than NN, the opposite was
found in RT-PCR (Table 1). We also validated by RT-PCR some of
the changes in TAN versus G-MDSC. In order to show that changes
are mainly due to the location of neutrophils (tumor versus spleen)
and not merely the time of isolation, the confirmation of these key
transcripts was done in neutrophils isolated from tumors and spleens
at the same time, both at an early time point (Day 14) and at a late
time point (Day 21) (Table 2).
We further evaluated the protein expression levels of several
cytokines and chemokines that were up-regulated in TAN, using
several methods to detect proteins. We found by ELISA of
conditioned media that several proteins had similar fold-changes
in their levels compared to the array in the different populations of
neutrophils (Fig. 3A). We also found up-regulation of TNF-a in
TAN compared to NN shown by intracellular flow cytometry. On
average 15.862.1% of TAN expressed TNF-a (n=5), versus
4.160.7% of NN (n=3). A sample dot plot is shown in Fig. 3B.
Up-regulation of CCL-17 was shown by immunoblotting of
isolated cells (Fig. 3C).
Evaluation of pathway and gene groups differences
In order to link genes to specific pathways, we evaluated key
pathways and gene groups using bioinformatic approaches.
Figure 2. Heatmaps comparing the most different genes between the 3 groups of neutrophils. (A) – Heatmap of genes with fold-change
between any two groups $30. The TAN exhibit a signature that is markedly different than the other two types of neutrophilic cells. (B) Heatmap with
all genes with a fold-change $8 between NN and G-MDSC, showing a clearly different signature in these two groups of cells. Red – up-regulation;
Blue – down-regulation; White – no change from mean.
doi:10.1371/journal.pone.0031524.g002
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neutrophil populations, comparing TAN and NN (Fig. 4), TAN
and G-MDSC (Fig. 5) and G-MDSC and NN (Fig. 6). We further
directly evaluated pathways and gene groups related to previously
described neutrophil functions and activities. These changes,
presented below, are summarized in Table 3.
Structural genes. There was down regulation in TAN of
pathways related to cytoskeleton organization and biogenesis, and
those related to actin binding and polymerization (e.g. Actn-1/4,
Raf-1, LCP-1 and Talin-1).
Respiratory Burst. There are several gene groups and
pathways associated with the respiratory burst [19,20]. Peroxidase
activity genes were down-regulated in TAN compared to NN
(Fig. 4).Although the NADPHoxidase complexgenes [21] werenot
significantly changed in the different neutrophil populations, we
noted a trend toward down-regulation of several genes in this
pathway, i.e. neutrophilic cytosolic factors 1 (p47phox) and 2
(p67phox), as well asRAC-1and RAC-2in TAN, compared to NN.
Furthermore, we found a significant down-regulation of the fMLP
signaling pathway, and its related ERK-1/ERK-2 MAPK signaling
pathway, in TAN, compared both to naı ¨ve neutrophils (Fig. 4) and
to splenic G-MDSC (Fig. 5).
Expression of Toll-like receptor (TLR) signaling genes were low
in NN, with marked up-regulation in G-MDSC (Fig. 6). Some of
these genes were also up-regulated in TAN compared to NN (i.e.
TLR-1, TLR-4 and IRAK-2), but as a group of genes, there were
not up-regulated in TAN. There was no change between the
different populations in the PMA-stimulated respiratory burst
pathway genes (PKC genes).
Granule proteins. Neutrophils contain effector granule
proteins, stored in primary, secondary and tertiary granules [22].
Although these proteins were not differently expressed as a group,
we found that several of these proteins were up-regulated in NN,
and to a lesser extent in G-MDSC, compared to TAN where their
expression levels were very low. Some of the primary granule
genes were significantly and markedly elevated only in NN (i.e.
MPO, Proteinase-3 and Cathepsin-G). Interestingly, there was no
significant difference in the expression of neutrophil elastase (ELA-
2) between the 3 groups of neutrophils. Several secondary granule
genes (e.g. MMP-8, CAMP, lactoferrin and NGAL), and most
tertiary granule genes (e.g. CD11b, MMP-9 and PGLYRP), were
markedly up-regulated in NN, and to some extent also in G-
MDSC, compared to TAN.
Phagocytosis. Wefound no clear changes inthe pathways and
genes related to phagocytosis, as clustered by Theilgaard-Monch et.
al. [22]. Interestingly, genes related to proteolysis (e.g. MMP-13/14
and TIMP-1) and fibrinolysis were up-regulated in TAN.
Apoptosis. Given data that TAN appear to persist longer
than circulating neutrophils [23], we further evaluated some gene-
groups related to apoptosis, in both the intrinsic (mitochondrial)
and extrinsic (cytosolic, death receptor signaling) pathways [24].
As a whole, there was no significant difference in the apoptosis-
related genes and pathways between the 3 populations. All three
populations of neutrophils had comparably low levels of genes
related to the p53-DNA damage pathway (e.g. p53, MDM-2,
ATR, CHEK-1/2 etc.). There was also no clear unidirectional
change in the pro-apoptotic and anti-apoptotic regulators of the
extrinsic pathway (i.e. TRAIL, Caspase-10). The release of pro-
apoptotic proteins from mitochondria, a critical checkpoint in the
intrinsic pathway, is regulated by the Bcl-2 family [24]. G-MDSC
neutrophils had a clear up-regulation in all pro-apoptotic BH3-
only genes, important regulators of this process (i.e. BIM, NOXA,
PUMA and BID). We could not find a clear change in this
pathway in TAN towards either a pro- or anti-apoptotic direction.
In contrast, we found up-regulation of several anti-apoptotic
members of the NF-kB family (e.g. IEX-1, SOD-2, GADD-45b
and BCL-2A1), in TAN compared to both NN and G-MDSC,
whereas the changes in pro-apoptotic members of this family
varied.
Neutrophils as Antigen Presenting Cells. We found up-
regulation in pathways related to the role of neutrophils as antigen
presenting cells (APC’s) to be a major change in G-MDSC and
TAN. When comparing G-MDSC to NN, many of the up-
regulated genes and pathways were related to APC function,
including general antigen processing and presentation genes, those
specifically related to presentation of exogenous peptides (e.g.
CD74, Cd1d-1, Psme1, etc.), all six MHC-II protein complex
Table 2. Validation of array results by real time PCR - Ratio of
expression in TAN compared to G-MDSC.
Gene (mRNA) Array RT-PCR
(14 days) (21 days)
CCL-17 23.5 ++ 79.2
TREM-1 0.43 ,0.01 ,0.01
CD9 0.24 0.21 0.42
IL-6 2.5 8.3 1.6
VEGF 2.5 1.1 1.3
CCL3 1.3 1.4 2
CCL5 1.4 1.2 0.65
CXCL10 0.7 1.2 ND
Confirmation of selected results from the microchip array using real time RT-
PCR in isolated tumor associated neutrophils (TAN) from flank tumors of two
separate tumor cell lines – the mesothelioma cell line AB12 (Balb/C), and the
NSCLC cell line LKR (B6-129/J1). Table shows the gene fold-change of TAN to
Naı ¨ve neutrophils (NN) using the arrays or by RT-PCR measurements.
++ - Fold-change .100, ND – Not Done.
doi:10.1371/journal.pone.0031524.t002
Table 1. Validation of array results by real time PCR - Ratio of
expression in TAN compared to NN.
Gene (mRNA) Array RT-PCR
(AB12) (LKR)
ICAM-1 5.1 7.6 2.7
KC/CXCL-1 131.5 75.9 +++
MIP-2a/CXCL-2 188.7 ++ +++
IP-10/CXCL-10 2.7 1.8 ++
CCL-3/MIP-1a 77.6 7.7 +++
CCL-17 25.9 +++ +++
CCL-2/MCP-1 6.6 +++ ND
CCL-5/Rantes 12.3 9.6 ND
VEGF 2.9 0.5 ND
MMP9 0.37 ,0.01 ND
Confirmation of selected results from the microchip array using real time RT-
PCR in isolated tumor associated neutrophils (TAN) from flank tumors of two
separate tumor cell lines – the mesothelioma cell line AB12 (Balb/C), and the
NSCLC cell line LKR (B6-129/J1). Table shows the gene fold-change of TAN to
Naı ¨ve neutrophils (NN) using the arrays or by RT-PCR measurements.
++ - Fold-change .100, +++ - Fold-change .500, ND – Not Done.
doi:10.1371/journal.pone.0031524.t001
TAN Differ from Naı ¨ve Neutrophils and G-MDSC
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receptor pathway genes (i.e. TLR-2/6, Fos, Myd88, Jun, etc.)
(Fig. 6). The same groups and pathways of genes, except for the
Toll-like receptor pathways were also significantly up-regulated
when TAN were compared to NN (Fig. 4). There was no
significant difference in these pathways between G-MDSC and
TAN (Fig. 5). Interestingly, the co-stimulatory molecules CD80
and CD86 were both up-regulated in the G-MDSC compared to
NN, and further up-regulated in TAN.
Other immune effects and chemokines. Compared to
naı ¨ve neutrophils, both TAN (Fig. 4) and G-MDSC (Fig. 6) were
enriched in pathways related to immune responses and processes
as a whole, inflammatory responses, cytokine activity (e.g. TNF-a,
IL-1a, IL-1b, IL-12), and receptor binding. Although up-
regulation of these immune-related genes were noted in G-
MDSC, TAN were further enriched compared to G-MDSC in
immune system responses and especially in chemotaxis (Fig. 5).
One of the major changes in mRNA expression comparing the
three neutrophil populations was in chemokine gene expression. Of the
51 genes significantly up-regulated by more than 5-fold in G-MDSC
compared to NN (Fig. 2B), 4 were chemokines. Changes were even
more prominent when comparing TAN to NN and G-MDSC. For
example, of the 86 genes significantly up-regulated by more than 8-fold
in TAN compared to G-MDSC, nine were chemokines. Figure 7 is a
specific heatmap using all the 25 chemokines present on the
microarray. Compared to TAN, NN and G-MDSC were relatively
similar to each other in terms of their chemokine profile. CXCL-4 and
CXCL-12 were increased in the NN, whereas CCL-3, CCL-4 and
CXCL-2 were down-regulated compared with G-MDSC.
In contrast, TAN were quite different than both of these other
groups with 13 of these chemokines being markedly up-regulated.
These changes included a striking up-regulation of chemoattrac-
tants for T-cells (e.g. CCL-17, CXCL-9, CXCL10 and CXCL-16),
neutrophils (eg. CXCL-1, CXCL2 and CCL-3), B-cells (CXCL-13)
and macrophages (e.g. CCL-2, CXCL-10 and CCL-7).
Discussion
Although neutrophils are traditionally considered in the context
of their anti-bacterial functions, it is becoming increasingly clear
that tumor-associated neutrophils (TANs) and their myeloid
precursors (peripheral neutrophils and granulocytic MDSC) in
the spleen, bone marrow, and blood play an important role in
cancer biology [4,7,14,25]. In contrast to the well-described ability
of inflammatory neutrophils to engulf bacteria, activate the
immune system, and induce tissue damage in infections [26], it
appears that myeloid cells can also function as immunosuppressive
cells in the context of tumors [27]. This property has been very
well described in recent years for the MDSCs found in large
quantities in the spleens of tumor-bearing animals [27,28,29,30]
and for tumor-associated macrophages which develop an ‘‘M2’’ or
tumor-supportive phenotype [1,3]. Neutrophils make up a
significant portion of the inflammatory cell infiltrate in many
models of cancer. Previous studies have shown that TAN in
untreated tumors can support tumor growth and metastases [31],
and this was further supported by our recent work demonstrating
that in untreated tumors, TAN develop a pro-tumorigenic (N2)
phenotype, largely driven by the presence of TGF-b [4]. The full
range of mechanisms responsible for this activity have not yet been
elucidated, but neutrophils are known to have pathways that can
impact angiogenesis, immune surveillance, as well as secretion of
chemokines, cytokines and reactive oxygen species [11,25].
Figure 3. Validation of array results at the protein level. (A) – comparison between the secretions of the different cytokines to the supernatant
following isolation of each of the neutrophil populations. (B) – An example of TNF-a levels in Ly6G
+ neutrophils, comparing TAN (left)to NN (right).
A clear up-regulation, similar to the increased m-RNA in the array and in RT-PCR is shown. (C) – An immunoblot, showing the expression of CCL-17
in a protein extract of TAN (left), and the lack of expression in protein extract of NN (right).
doi:10.1371/journal.pone.0031524.g003
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neutrophils (NN). Each sample was evaluated for changes in the different pathways, and was marked as positive when $3 genes were significantly
changed to the same direction. In each panel - Right - Pathways/Groups that had more than 5 samples changed. Left - Pathways/Groups that were
significantly changed when the groups were compared to each other (p,0.05, corrected). Red – up-regulation; Blue – down-regulation; Black – no
change from mean.
doi:10.1371/journal.pone.0031524.g004
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thegoalofthepresentstudywastouseanunbiased,discovery-based
approach (gene array analysis) to profile and compare the mRNA
content of three highly purified granulocytic populations: ‘‘naı ¨ve’’
bone-marrow neutrophils from non-tumor-bearing animals (NN)
[serving as the ‘‘baseline’’ control population], the granulocytic
fraction of myeloid-derived suppressor cells (G-MDSC) in tumor
bearing mice, and tumor-associated neutrophils. Our purpose was
to gain additional information on the characteristics of TAN, and
specifically how much they resembled the other neutrophil
populations. A caveat of this study is that we restricted our initial
analysis to primarily transcriptomic information. Although we have
conducted some functional studies [4], additional experiments,
based on this genomic information, will obviously be needed to fully
understand the role and functions of TAN.
Using unbiased analyses, our data show that the three
populations of neutrophils are significantly different in their
mRNA profiles. However, it appears that the NN and G-MDSC
are more closely related to each other than to TAN. To better
understand the meaning of these differences, we used pathway
analyses (using Genomica software, and published gene lists)
focusing on several selected pathways and gene groups important
for the function and activation of neutrophils including structural
genes, respiratory burst, granule proteins, phagocytosis, apoptosis,
and immune functions.
NN were relatively enriched in cytoskeleton organization and
biogenesis, as well as in pathways related to actin binding and
polymerization. This is probably related to the movement needed
by neutrophils prior to arriving to their destination [32].
Interestingly these gene pathways are down-regulated in TAN,
consistent with their loss of ability to leave the tumor microen-
vironment after infiltrating the tumor.
The two pathways needed to carry out the ‘‘anti-bacterial’’
functions of neutrophils, granule protein production and the
Figure 5. Analysis of pathways and gene groups using Genomica, comparing tumor associated neutrophils (TAN) to the
granulocytic fraction of myeloid derived suppressor cells (G-MDSC). Each sample was evaluated for changes in the different pathways, and
was marked as positive when $3 genes were significantly changed to the same direction. In each panel - Right - Pathways/Groups that had more
than 5 samples changed. Left - Pathways/Groups that were significantly changed when the groups were compared to each other (p,0.05, corrected).
Red – up-regulation; Blue – down-regulation; Black – no change from mean.
doi:10.1371/journal.pone.0031524.g005
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NN. These pathways are progressively lost in the G-MDSC, and
even more dramatically in the TAN. TAN show a dramatic down-
regulation in mRNA levels of all three groups of granule proteins,
which are highly expressed in NN. This finding could be consistent
with the work by Shen et. al. showing that TGF-b can inhibit
neutrophils degranulation [33]. Given that the two main
mechanisms of cell killing by neutrophils (respiratory burst and
granule proteins) are both down-regulated in TAN, these findings
are compatible with our previously published functional data
showing that TAN had low cytotoxic capabilities for tumor cells
[4]. An alternative explanation for these findings could be that the
mature neutrophils, either G-MDSC or TAN, have finished
producing granule contents, and the relevant mRNA are not
needed any longer [22], or that the more mature populations have
degranulated. If so, these differences may only be a reflection of
the fact that NN are less mature. Even if that explains the up-
regulation of these mRNAs in NN, there is a further down-
regulation in TAN compared to G-MDSC, suggesting a possible
effect at the RNA level as well. Again, it is also possible that these
differences reflect that G-MDSC are circulatory neutrophils,
whereas TAN are in the tissue. The mRNA for neutrophil elastase,
a major effector molecule in the activity of neutrophils in general,
and specifically in cancer [25], was surprisingly not different
between the 3 populations. It is possible that the modifications in
the level of this molecule are post-translational, or that it is needed
for the proper activity of neutrophils in either compartment.
Further research to evaluate actual production and secretion of the
different granule proteins is warranted. The only pathway related
to respiratory burst where some members were up-regulated in
TAN was the toll-like receptor (TLR) family, probably more
related to associated immune system changes (see below).
Figure 6. Analysis of pathways and gene groups using Genomica, comparing naı ¨ve neutrophils (NN) to the granulocytic fraction of
myeloid derived suppressor cells (G-MDSC). Each sample was evaluated for changes in the different pathways, and was marked as positive
when $3 genes were significantly changed to the same direction. In each panel - Right - Pathways/Groups that had more than 5 samples changed.
Left - Pathways/Groups that were significantly changed when the groups were compared to each other (p,0.05, corrected). Red – up-regulation;
Blue – down-regulation; Black – no change from mean.
doi:10.1371/journal.pone.0031524.g006
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genes related to phagocytosis, another major function of
neutrophils. This was further confirmed by evaluating the genes
suggested by Huang et. al. to be phagocytic receptors or genes
involved in phagocytic signaling [19] (data not shown).
Despite data suggesting that TAN may be longer lasting cells
than circulating neutrophils [23], we found that most genes related
to apoptosis were expressed at similar levels. However, we did find
that several anti-apoptotic members of the NF-kB family were up-
regulated in TAN. NF-kB may be, therefore, an important
regulator of the anti-apoptotic machinery in TAN and it is possible
that this pathway is responsible for the notable longevity of TAN
compare to other neutrophils. Interestingly, we found an up-
regulation of all the BH3 pro-apoptotic genes in G-MDSC
neutrophils, suggesting that these cells might be especially sensitive
to apoptosis-mediated by death receptor ligands.
It has become increasingly clear that the contribution of
neutrophils to host defense and natural immunity extends well
beyond their traditional role as professional phagocytes [34].
Neutrophils and their myeloid precursors can be induced to
express a number of genes whose products lie at the core of
inflammatory and immune responses, suggesting a potential role
for these cells in orchestrating the sequential recruitment and
activation of distinct leukocyte types to the inflamed tissue [35].
Neutrophils from humans and mice are recognized as cellular
sources of chemokines in inflammatory responses [35]. ‘‘Immu-
nosculpting’’, i.e. the crosstalk between immune and tumor cells
changing the phenotype of tumor biology, is widely recognized
[36]. However, until recently, the role of neutrophils in this cross-
talk has been under-estimated. Our study suggests several potential
new pathways by which neutrophils can influence both the innate
and the adaptive immune system. Our data are also consistent
with the suggestion that a potential source for chemokines in
tumors are the intratumoral TAN, which constitute a notable
percentage of tumor immune cells.
One area of potential importance is in antigen presentation.
Accumulating data from the last decade shows that neutrophils
can participate in MHC class I and class II restricted antigen
presentation, being capable of collecting and cleaving antigens,
forming complexes with MHC-II molecules, and expressing co-
stimulatory molecules [34,37,38]. Our data show that the naı ¨ve
neutrophils lack many of the gene pathways needed to present
antigens, however, both TAN and G-MDSC show increased
expression of these genes, suggesting an enhanced capability of
functioning as APC’s. There was also up-regulation of the co-
stimulatory molecules CD80 and CD86. These results are consistent
with the abundant data on effects of tumor neutrophils and G-
MDSC on T-cells [4,27,39,40]. Interestingly, there was no clear
difference in this capability between G-MDSC and TAN, possibly
suggesting that this isa fundamentalpartofactivation of neutrophils,
regardless of their specific role. An interesting and very important
issue, which will require functional studies to elucidate, is whether
neutrophil antigen presentation induces T cell activation or anergy.
It has been recently shown that mature neutrophils can function as
professional antigen-presenting cells capable of priming a Th-1 and
Th-17-acquired immune response [38].
The most prominent difference that we found between TAN,
and either NN or G-MDSC, was the significant up-regulation of
cytokines and chemokines. This change suggests an important role
of tumor neutrophils in the recruitment of immunocytes and in the
balance between activation and suppression of the immune
system. The role of chemokines in the pathogenesis of cancer
has been increasingly appreciated [41]. Among the broad group of
chemokines whose mRNAs were up-regulated in TAN were the
CCL chemokines 2, 3, 4, 8, 12, and 17 and the CXCL chemokines
1, 2, 9, and 16. The up-regulation of chemokines in TAN suggests
that upon entering the tumor, TAN have a pivotal role in
recruiting other cells of the immune system to the tumor. This is
similar to the role that ‘‘classical neutrophils’’ would have in
wound healing. At least some of the recruited cells are known to
support tumor growth, such as macrophages (by CCL-2 and CCL-
7) and T-regulatory cells (by CCL-17) [42]. The increased
secretion of CCL-2, CCL-17 and IL-6 was demonstrated at the
protein level as well.
Special attention should be given to our data on neutrophil
chemoattractants and their chemokine receptors. Ueha et. al have
recently summarized the dynamics of myeloid cells, including
neutrophils, from the bone marrow to the circulation and into
tumors [43]. CXCR-2 and CXCR-4 were shown to cooperatively
regulate the release of neutrophils from bone marrow [44].
Whereas the expression of CXCR-2 was not evaluated in this
array, CXCR-4 was highly expressed in all 3 neutrophil
populations. Its expression, however, was mildly down-regulated
in the splenic neutrophils and in TAN. Ueha et. al. further suggest
that tumor-infiltration by neutrophils is at-least partly mediated by
Table 3. Summary of the relative changes in the different
neutrophil populations.
Neutrophil Function NN G-MDSC TAN
Structural genes Cytoskeleton ++ 2
Actin Binding ++ 2
Respiratory Burst Peroxidase ++ ++ 2
NADPH complex ++ + 2/+
TLR 2 ++ +
Granule Proteins Primary +++ 22
Secondary ++ + 2
Tertiary ++ + 2
Phagocytosis Whole group +/2 +/2 +/2
Proteolysis/Fibrinolysis +/2 +/2 +
Apoptosis Whole group ++ +
P53 pathway 22 2
Extrinsic pathway +/2 +/2 +/2
Intrinsic (BCL2) Pathway ++ ++
(BH-3)
+/2
NF-kB – pro apoptotic +/2 +/2 +/2
NF-kB – Anti apoptotic ++ +/2 +/2
Immune system Whole group 2 ++ ++
APC genes 2 ++ ++
Cytokine activity 2 ++ ++
Chemokines 2 ++ +++
Pathways and gene-groups were evaluated by the Genomica software, and
manually from the literature. The data of each neutrophils-function evaluated
for each population of neutrophils is presented.
(2) - Most genes in the pathway/group were at background levels.
(+/2) – Some genes of the pathway/group were up-regulated and other down-
regulated.
(+) – A related pathway/group was up-regulated (Genomica), or some (.10%)
of the genes in the group were up-regulated (manually).
(++) – A related pathway/group was up-regulated (Genomica), and/or a
significant portion (.30%) of the genes in the group were up-regulated
(manually).
(+++) – A prominent up-regulation of genes in the group/pathway (.50%) was
noted.
doi:10.1371/journal.pone.0031524.t003
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of CXCL-2 was markedly up-regulated in G-MDSC compared to
NN (71-fold), and even more in TAN (188-fold compared to NN).
Interestingly, we found similar results in two other known
neutrophils chemoattractants – CXCL-1 (increased 14-fold in G-
MDSC and 140-fold in TAN compared to NN), and CCL-3
(increased 60-fold in G-MDSC and 76-fold in TAN compared to
NN). Unfortunately GCP-2/CXCL-6 was not part of the Illumina
array we used, and therefore we could not assess changes in this
previously-described [45] neutrophil chemoattractant. It seems
therefore, that the neutrophils begin a positive feedback loop by
secreting neutrophil chemoattractants that recruit more neutro-
phils into the tumor, as previously described in infections [46,47].
It is worth considering the relationship between TAN and the
granulocytic fraction of myeloid-derived suppressor cells (G-
MDSC) in light of our results. MDSC, a heterogeneous population
of immune suppressive cells that are produced at high levels in
cancer, are defined in mice on the basis of expression of the surface
markers CD11b and GR1 and by their ability to inhibit T
lymphocyte activation. The CD11b
+/GR1
+ MDSC population is
comprised of at least two subsets - granulocytic (Ly6G
+) and
monocytic cells (Ly6C
+), possibly with different immunosuppres-
sive properties [14]. There is substantial agreement on the
immunosuppressive activity of the monocytic MDSC subset.
However, there is still contradictory evidence on the role of the
granulocytic fraction. Whereas some have shown that granulocytic
Figure 7. Heatmap comparing the expression of chemokines in the three groups of neutrophils - naı ¨ve neutrophils (NN),
granulocytic fraction of myeloid derived suppressor cells (G-MDSC) and tumor associated neutrophils (TAN), clearly showing that
many chemokines were up-regulated in the TAN group. Red – up-regulation; Blue – down-regulation; White – no change from mean.
doi:10.1371/journal.pone.0031524.g007
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fraction [28,29,30], others have recently demonstrated that they are
less immunosuppressive [14,48,49]. It has been previously shown that
adoptively transferred MDSC can enter tumors and differentiate to
mature macrophages (TAM) or neutrophils (TAN) [15], however
little is known in animals about whether MDSC leave the spleen and
circulate. It is thus not clear whether the majority of TAN are actually
G-MDSC that have been attracted to the tumor or whether they are
bone marrow/blood-derived neutrophils that were then converted to
N2 TAN by the tumor microenvironment, specifically by the high
local concentrations of TGF-b [4]. In our previously published work,
we saw no effects of TGF-b blockade on the percentage or phenotype
of blood neutrophils or splenic MDSC [4]. In the current study, we
clearly show that TAN are not ‘‘tissue-based G-MDSC’’, but are a
distinct population of neutrophils, differing markedly in their
transcriptomic profile from both NN and G-MDSC. Taken together,
these data support the idea that tumor TGF-b (and perhaps other
factors) changes only the local ‘‘education’’ of neutrophils. However,
the studies described here cannot definitively determine if the cells
were recruited from the bone marrow/blood pool of neutrophils or
the splenic G-MDSC population.
A possible limitation of our study is that it was performed only in
one type of tumor, i.e. the mesothelioma cell line AB12. We did
confirm some ofthe results ina differentcellline – thenon-smallcell
lung cancer LKR-M. However further analysis is needed in order to
establish the generalization of our data to other tumor systems. It is
also possible to argue that since cells were collected at different time
points during tumor progression, some of the differences in RNA
profiles observed may be due to the time-point at which the cells
were isolated (earlier or later during tumor growth) and not their
location in the spleen or tumor. Since little is known about the
kinetics of the development of TAN, and it is well established that
G-MDSC arise only at later time in tumor development [28], we
decided to do our comparisons using well-established G-MDSC
(associated with larger tumor size) and TAN from established, but
not necrotic tumors (less than 500 mm
3). However, we also
confirmed some of our data in key transcripts, using RT-PCR of
neutrophils isolated from tumors and spleens at the same time, both
at an early and a late time point (Day 14 and Day 21), and showed
that similar differences to those seen in the arrays were noted. The
important question of the kinetics of the changes in tumor and
spleen neutrophils will be addressed in future research.
Our data confirm that the native tumor microenvironment
influences the mRNA program of neutrophils. We have previously
shown that these cells have pro-tumor characteristics [4]. We have also
shown that altering the tumor microenvironment by blocking the
effects of TGFb can further alter the phenotype of TANs to a more
‘‘anti-tumor phenotype (N1 TAN). We are currently comparing gene
arrays of N1 and N2 TAN and are seeing clear changes in chemokines
and cytokines profile between these two populations of neutrophils
(manuscript in preparation), suggesting that the specific profile of
chemokines secreted is a major characteristic of TAN and a
determinant in their polarization. One example is that the T regulatory
cell chemoattractant, CCL-17, is up-regulated in N2 versus N1 TAN.
In their recent review on TAN as targets for cancer therapy,
Gregory and Houghton argued that changes in TAN are not a
switch to a unique transcriptional program, but a heightened state
of activation [25]. Borregaard et. al. suggested that circulating
neutrophils have two major bursts of transcriptional and protein
synthetic activities – one in the bone marrow, producing the
granules, and the second upon migration into tissues, resulting
mainly in the secretion of cytokines and chemokines [20]. The
data we presented here suggests that neutrophils may have a
different program if they reside in the spleen, becoming G-MDSC
or upon entering the tumor, becoming TAN. If so, these 3
neutrophil populations do have different transcription programs
that separate them. It remains to be seen if the differences noted
are merely different activation states that can be reversible.
Significant research has recently been done elucidating the
important role of myeloid cells in the cancerous process. Our work
adds another important layer to the understanding of neutrophils
in cancer by further characterizing the different populations of
neutrophils induced by tumors and by pointing out major
differences between TAN and other neutrophil populations.
Further research on the functional role of different pathways
and genes up-regulated in TAN and differences between the
different subsets of TAN is currently underway.
Materials and Methods
Ethics statement
This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was approved by
the Committee on the Ethics of Animal Experiments of the
University of Pennsylvania (Permit Number: 80-2606).
Animals
Mice were purchased from Taconic Labs (Germantown, NY),
and Jackson Labs (Bar Harbor, ME).
Cell lines
The murine malignant mesothelioma cell line, AB12 was
derived from an asbestos-induced tumor in a Balb/C mouse. The
murine lung cancer line LKR was derived from an explant of a
pulmonary tumor from an activated Kras G12D mutant mouse
that had been induced in an F1 hybrid of 129Sv.J and C57BL/6
[50].
Isolation of the different groups of neutrophils
NN – non-tumor-bearing mice were euthanized, and bone
marrow was harvested by flushing the femurs and tibias with
HBSS media. Cells were then separated by centrifugation over a
3 layer discontinuous Percoll gradient as previously described
[51].
G-MDSC - Mice were injected on the right flank with 1610
6
AB12 or LKR tumor cells in the appropriate syngeneic host. The
flank tumors were allowed to reach an average size of 500–
700 mm
3 (approximately 21–25 days). Mice were then eutha-
nized, and spleen was harvested. Neutrophils were isolated with
microbeads and flow cytometry (see below).
N2 TAN - Mice were injected on the right flank with 1610
6
AB12 or LKR tumor cells in the appropriate syngeneic host. The
flank tumors were allowed to reach an average size of 250–
300 mm
3 (approximately 12–15 days). Flank tumors were
harvested from the mice, minced, and digested with 2 mg/mL
DNase I (Sigma, St. Louis, MO) and 4 mg/mL collagenase type
IV (Sigma) at 37uC for 1 hour. Neutrophils were isolated with
microbeads and flow cytometry (see below). In one set of
experiments, both TAN and MDSC were harvested on the same
days- Day 14 and 21.
Isolation of neutrophils from spleens/tumors
Tumors/spleens were harvested, digested, and CD11b
+ cells
were isolated using magnetic beads (Miltenyi Biotec, Germany)
per manufacturer’s instructions. The CD11b
+ cells were then
‘‘flow sorted’’ using a Beckman-Coulter EPICS Elite ESP FACS
Sorter (Fullerton, CA), isolating CD11b
+/Ly6G
+ cells (neutro-
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Biosciences, Franklin lakes, NJ). In all samples a purity of above
85% neutrophils was achieved.
Gene microarray
mRNA preparations were extracted from individual mice,
and for each ‘‘sample’’, equivalent amounts of RNA were
pooled from 2–4 mice (according to the yield of neutrophils) for
the transciptome analysis. We prepared samples from each of
the neutrophil populations studied - NN (n=7), G-MDSC
(n=4) and TAN (n=4). Samples were processed and
h y b r i d i z e dt ot h eI l l u m i n am o u s eg e n o m eb e a da r r a y s .R a w
data was processed by Bead Studio v.3.0 software. Expression
levels were exported for signal and negative control probes.
The set of negative control probes was used to calculate average
background level for further filtering and background subtrac-
tion steps. Average values of the signal probe expression data
f o rt h e7( N N ) ,4( G - M D S C )a n d4( T A N )s a m p l ea r r a y sw e r e
used as a base for normalization and all the arrays were quintile
normalized against this base, and filtered to remove non-
informative probes. A probe was called non-informative if it
had detection p-value.0.05 in all samples or if the maximal
ratio between expression values of each two samples was lower
than 1.2. The three different groups were compared between
each other.
The microarray data complies with the MIAME guidelines, and
the data will be deposited in a publicly available database.
RNA isolation and real-time, reverse transcription-PCR
RNA from tumors/spleens/BM was isolated as above. For
each group, a pool of RNA was created by adding the same
amount of RNA from each of the samples within the group.
Absorbance at 260/280 nanometers for mRNA purity at a ratio
above 1.9 was achieved for all samples used. cDNA was made
from each pool, RNA levels were normalized to b-actin levels,
and quantification of tumor mRNA levels was performed as
previously described [4]. Each sample was run in quadruplicate
and the experiment was repeated at least once. Primer sequences
are given in Table S4.
Protein validation
In order to validate some of the RNA data at the protein level,
neutrophils were isolated as described above. Four million
isolated neutrophils were plated in each well of a 12-well plate
and covered with 1 ml of medium. After 24 hours, the
supernatant was collected, spun, and the level of different
proteins was evaluated using ELISA sets for IL-6 (BD Biosciences
Pharmingen, San Diego, CA) and CCL-2/MCP-1 (BD Biosci-
ences), and Duoset ELISAs for CXCL-2/MIP-2 and CXCL-10/
IP-10 (both from R&D Systems, Minneapolis, MN). For
validation of CCL-17, protein was extracted from the neutrophils
immediately following isolation, and an immunoblot was
performed using anti-CCL-17 Antibody (R&D Systems). TNF-a
levels were evaluated by intracellular flow cytometry. BM/Tumor
cells were treated with GolgiPlug (BD Biosciences) for 3 h.
Thereafter, TNF-a levels were evaluated by intracellular flow
cytometry using anti-TNF-a Ab (BioLegend, San Diego, CA) as
previously described [52].
Statistical Analyses
Gene array data was filtered following quintile normalization
as described above. Hierarchical clustering was done for
evaluation of similarity between samples in the same group,
followed by PCA analysis. To compare genes that are different
between at least two of the groups, we used one sided ANOVA
on the quintile normalization data with appropriate post hoc
testing.
Genomica software (http://genomica.weizmann.ac.il/) was
used to identify enrichment patterns of experimental signatures
associated with the different neutrophils groups [53,54]. We
evaluated about 2300 pathways and gene groups based on the
suggested ‘‘mouse GO’’ and ‘‘mouse Biocarta’’ murine gene
repositories. Data were log2 transformed and mean centered.
Genes whose expression was 2-fold or greater than the mean
expression level were scored. Enrichment of over-expressed or
under-expressed genes that belong to each tested gene signature
was calculated using a hypergeometric test and a false discovery
rate (FDR) calculation to account for multiple hypotheses testing
(p,0.05, FDR,0.05). The fraction of samples showing significant
enrichment for a particular gene signature in each group (BM/N2
TAN/G-MDSC) was calculated.
Heatmaps for lists of genes were composed using two-way
hierarchical clustering with normalized Euclidean distance to
cluster samples and Spearman correlation distance to cluster
genes, with the genes ordered accordingly. For some specific
neutrophilic functions, we manually evaluated the specific changes
of genes.
For the RT-PCR and FACS studies comparing differences
between two groups, we used unpaired Student t-tests. Differences
were considered significant when P,0.05. Data are presented as
mean+/2 SEM.
Supporting Information
Table S1 Comparison of the top 15 genes that were
changed when comparing naı ¨ve neutrophils (NN) to
Granulocytic MDSC (G-MDSC). The genes are shown in
order of fold change.
(DOC)
Table S2 Comparison of the top 15 genes that were
changed when comparing naı ¨ve neutrophils (NN) to
Tumor associated neutrophils (TAN). The genes are shown
in order of fold change.
(DOC)
Table S3 Comparison of the top 15 genes that were
changed when comparing Tumor associated neutrophils
(TAN) to Granulocytic MDSC (G-MDSC). The genes are
shown in order of fold change.
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Table S4 The sequences of the primers used for real-
time RT-PCR in this manuscript.
(DOC)
Author Contributions
Conceived and designed the experiments: ZGF SS GSW SMA. Performed
the experiments: ZGF JS GC IM VK WH GF RB. Analyzed the data:
ZGF WH GSW SMA. Contributed reagents/materials/analysis tools:
ZGF SS GSW SMA. Wrote the paper: ZGF SMA.
TAN Differ from Naı ¨ve Neutrophils and G-MDSC
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e31524References
1. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage
polarization: tumor-associated macrophages as a paradigm for polarized M2
mononuclear phagocytes. Trends Immunol 23: 549–555.
2. Balkwill F, Coussens LM (2004) Cancer: An inflammatory link. Nature 431:
405–406.
3. Yunping L, He Z, Krueger J, Kaplan C, Sung-Hyung L, et al. (2006) Targeting
tumor-associated macrophages as a novel strategy against breast cancer. Journal
of Clinical Investigation 116: 2132–2141.
4. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, et al. (2009) Polarization of
tumor-associated neutrophil phenotype by TGF-beta: ‘‘N1’’ versus ‘‘N2’’ TAN.
Cancer Cell 16: 183–194.
5. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S (2010) Neutrophils
responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a
mouse tumor model. J Clin Invest 120: 1151–1164.
6. Pekarek LA, Starr BA, Toledano AY, Schreiber H (1995) Inhibition of tumor
growth by elimination of granulocytes. J Exp Med 181: 435–440.
7. Shojaei F, Singh M, Thompson JD, Ferrara N (2008) Role of Bv8 in neutrophil-
dependent angiogenesis in a transgenic model of cancer progression.
Proceedings of the National Academy of Sciences 105: 2640–2645.
8. Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, et al. (2003) Infiltration of
neutrophils is required for acquisition of metastatic phenotype of benign murine
fibrosarcoma cells: implication of inflammation-associated carcinogenesis and
tumor progression. Am J Pathol 163: 2221–2232.
9. Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived
Hydrogen Peroxide are the underlying mechanism of suppression of T-Cell
function in advanced cancer patients. Cancer Res 61: 4756–4760.
10. Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the
initial angiogenic switch in a mouse model of multistage carcinogenesis.
Proceedings of the National Academy of Sciences 103: 12493–12498.
11. Piccard H, Muschel RJ, Opdenakker G (2011) On the dual roles and polarized
phenotypes of neutrophils in tumor development and progression. Crit Rev
Oncol Hematol.
12. Kobayashi Y (2008) The role of chemokines in neutrophil biology. Front Biosci
13: 2400–2407.
13. Wang LC, Thomsen L, Sutherland R, Reddy CB, Tijono SM, et al. (2009)
Neutrophil influx and chemokine production during the early phases of the
antitumor response to the vascular disrupting agent DMXAA (ASA404).
Neoplasia 11: 793–803.
14. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-
derived suppressor cell heterogeneity and subset definition. Current Opinion in
Immunology 22: 238–244.
15. Kusmartsev S, Nagaraj S, Gabrilovich DI (2005) Tumor-Associated CD8+ T
Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells.
J Immunol 175: 4583–4592.
16. Raymond F, Metairon S, Borner R, Hofmann M, Kussmann M (2006)
Automated target preparation for microarray-based gene expression analysis.
Anal Chem 78: 6299–6305.
17. Rajeevan MS, Vernon SD, Taysavang N, Unger ER (2001) Validation of array-
based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3:
26–31.
18. Bosotti R, Locatelli G, Healy S, Scacheri E, Sartori L, et al. (2007) Cross
platform microarray analysis for robust identification of differentially expressed
genes. BMC Bioinformatics 8 Suppl 1: S5.
19. Huang LT, Paredes CJ, Papoutsakis ET, Miller WM (2007) Gene expression
analysis illuminates the transcriptional programs underlying the functional
activity of ex vivo-expanded granulocytes. Physiol Genomics 31: 114–125.
20. Borregaard N, Sorensen OE, Theilgaard-Monch K (2007) Neutrophil granules:
a library of innate immunity proteins. Trends Immunol 28: 340–345.
21. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev
Immunol 4: 181–189.
22. Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD,
et al. (2005) The transcriptional program of terminal granulocytic differentia-
tion. Blood 105: 1785–1796.
23. Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, et al. (2008)
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in
tumor-bearing mice. Blood 111: 5457–5466.
24. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:
205–219.
25. Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets
for cancer therapy. Cancer Res 71: 2411–2416.
26. Ashtekar A, Bhaskar S (2003) Poly’s plea: membership to the club of APC’s.
Trends in Immunology 24: 485–490.
27. Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI (2010) Mechanism of
T cell tolerance induced by myeloid-derived suppressor cells. J Immunol 184:
3106–3116.
28. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloid-
derived suppressor cells in tumor-bearing mice. J Immunol 181: 5791–5802.
29. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C,
et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor
cell subpopulations with distinct T cell-suppressive activity. Blood 111:
4233–4244.
30. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators
of the immune system. Nat Rev Immunol 9: 162–174.
31. Opdenakker G, Van Damme J (1992) Chemotactic factors, passive invasion and
metastasis of cancer cells. Immunol Today 13: 463–464.
32. Zhelev DV, Alteraifi A (2002) Signaling in the Motility Responses of the Human
Neutrophil. Ann Biomed Eng 30: 356–370.
33. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, et al. (2007) Inhibition of
human neutrophil degranulation by transforming growth factor-beta. Clinical
and Experimental Immunology 149: 155–161.
34. Ashtekar AR, Saha B (2003) Poly’s plea: membership to the club of APCs.
Trends Immunol 24: 485–490.
35. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, et al. (2000) The
neutrophil as a cellular source of chemokines. Immunological Reviews 177:
195–203.
36. Reiman JM, Kmieciak M, Manjili MH, Knutson KL (2007) Tumor
immunoediting and immunosculpting pathways to cancer progression. Semin
Cancer Biol 17: 275–287.
37. van Gisbergen KP, Geijtenbeek TB, van Kooyk Y (2005) Close encounters of
neutrophils and DCs. Trends Immunol 26: 626–631.
38. Abi Abdallah DS, Egan CE, Butcher BA, Denkers EY (2011) Mouse neutrophils
are professional antigen-presenting cells programmed to instruct Th1 and Th17
T-cell differentiation. Int Immunol 23: 317–326.
39. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, et al. (2001) The
intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood
97: 339–345.
40. Kousis PC, Henderson BW, Maier PG, Gollnick SO (2007) Photodynamic
Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils.
Cancer Res 67: 10501–10510.
41. White ES, Strieter RM, Arenberg DA (2002) Chemokines as therapeutic targets
in non-small cell lung cancer. Curr Med Chem Anticancer Agents 2: 403–417.
42. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific
recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege
and predicts reduced survival. Nat Med 10: 942–949.
43. Ueha S, Shand FH, Matsushima K (2011) Myeloid cell population dynamics in
healthy and tumor-bearing mice. Int Immunopharmacol 11: 783–788.
44. Eash KJ, Greenbaum AM, Gopalan PK, Link DC (2010) CXCR2 and CXCR4
antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin
Invest 120: 2423–2431.
45. Fan X, Patera AC, Pong-Kennedy A, Deno G, Gonsiorek W, et al. (2007)
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/
CXCL8. J Biol Chem 282: 11658–11666.
46. Appelberg R (1992) Mycobacterial infection primes T cells and macrophages for
enhanced recruitment of neutrophils. J Leukoc Biol 51: 472–477.
47. Kobayashi Y (2006) Neutrophil infiltration and chemokines. Critical Reviews in
Immunology 26: 307–315.
48. Morales J, Kmieciak M, Knutson K, Bear H, Manjili M (2010) GM-CSF is one
of the main breast tumor-derived soluble factors involved in the differentiation of
CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor
cells. Breast Cancer Research and Treatment 123: 39–49.
49. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, et al. (2010)
Hierarchy of immunosuppressive strength among myeloid-derived suppressor
cell subsets is determined by GM-CSF. European Journal of Immunology 40:
22–35.
50. Wilderman MJ, Sun J, Jassar AS, Kapoor V, Khan M, et al. (2005)
Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly
effective in a murine orthotopic model of bronchogenic adenocarcinoma of the
lung. Cancer Res 65: 8379–8387.
51. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, et al. (2000) Role of p38
Mitogen-Activated Protein Kinase in a Murine Model of Pulmonary
Inflammation. The Journal of Immunology 164: 2151–2159.
52. Fridlender ZG, Kapoor V, Buchlis G, Cheng G, Sun J, et al. (2011) Monocyte
chemoattractant protein-1 blockade inhibits lung cancer tumor growth by
altering macrophage phenotype and activating CD8+ cells. Am J Respir Cell
Mol Biol 44: 230–237.
53. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An
embryonic stem cell-like gene expression signature in poorly differentiated
aggressive human tumors. Nat Genet 40: 499–507.
54. Carretero J, Shimamura T, Rikova K, Jackson AL, Wilkerson MD, et al. (2010)
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient
metastatic lung tumors. Cancer Cell 17: 547–559.
TAN Differ from Naı ¨ve Neutrophils and G-MDSC
PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e31524